US2020054708A1PendingUtilityA1
Pharmaceutical composition for promoting neurogenesis and method of utilizing gastrodia elata extract or adenosine analog for promoting neurogenesis
Est. expiryAug 20, 2038(~12.1 yrs left)· nominal 20-yr term from priority
A61K 36/8988A61K 31/7076A61P 25/00A61K 31/7034A61K 31/11A61K 31/05A61K 31/365A61P 25/28A61K 31/19A61K 31/115
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a composition and a method of utilizing Gastrodia elata extract or an adenosine analog to promote neurogenesis, wherein the G. elata extract includes gastrodin, gastrodigenin, parishins, N6-(4-hydroxybenzyl) adenosine (T1-11) and 4-hydroxybenzaldehyde. The G. elata extract of the present invention exhibits anti-aging activity on nerve cells and can induce neurogenesis in mouse hippocampus.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A pharmaceutical composition for promoting neurogenesis, comprising:
gastrodin, gastrodigenin, parishins, N 6 -(4-hydroxybenzyl) adenosine (T1-11) and 4-hydroxybenzaldehyde.
2 . The pharmaceutical composition for promoting neurogenesis according to claim 1 , wherein the parishins comprises parishin A, parishin B, parishin C or parishin E.
3 . The pharmaceutical composition for promoting neurogenesis according to claim 1 , wherein a weight percentage of N 6 -(4-hydroxybenzyl) adenosine is 0.5-4%.
4 . The pharmaceutical composition for promoting neurogenesis according to claim 1 , wherein a weight percentage of gastrodin is greater than 25%.
5 . The pharmaceutical composition for promoting neurogenesis according to claim 1 , wherein a weight percentage of parishins is greater than 50%.
6 . A method of utilizing Gastrodia elata extract for promoting neurogenesis, wherein the G. elata extract comprises gastrodin, gastrodigenin, parishin, N 6 -(4-hydroxybenzyl) adenosine (T1-11) and 4-hydroxybenzaldehyde.
7 . The method according to claim 6 , wherein new born neurons are brain neurons.
8 . The method according to claim 6 , wherein a weight percentage of N 6 -(4-hydroxybenzyl) adenosine is 0.5-4%, a weight percentage of gastrodin is greater than 25%, and a weight percentage of parishins is greater than 50%.
9 . A method of utilizing isolated N 6 -(4-hydroxybenzyl) adenosine (T1-11) or its pharmaceutical accepted salts for promoting neurogenesis.
10 . The method according to claim 9 , wherein new born neurons are brain neurons.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.